SANI Membranes

Executive Summary

SANI Membranes is a Danish cleantech company founded in 2013 that has developed proprietary filtration technologies for the pharmaceutical and biotech industries. The company's core innovations—the Vibro® Membrane Filtration (VMF) technology and the Free Flow Plate™—are designed to overcome the limitations of conventional micro- and ultrafiltration processes. By introducing gentle, scalable, and highly efficient filtration, SANI Membranes enables better preservation of sensitive biomolecules while improving process economy and product quality. This positions the company as a key enabler for the production of advanced therapies, including monoclonal antibodies, vaccines, and gene therapies, where traditional filtration methods often cause damage or yield losses. Despite being a private company with limited public disclosures, SANI Membranes has established itself as a niche player in the bioprocessing equipment space, with potential to capture significant market share as the industry shifts toward more efficient and gentle downstream processing solutions.

Upcoming Catalysts (preview)

• Q3 2026Strategic Partnership with a Top-20 Pharma Company for VMF Adoption70% success
• Q4 2026FDA or EMA Recognition of VMF as a Validated Manufacturing Technology60% success
• Q2 2026Series C Funding to Scale Production and Sales75% success